Physician profile
Robert L Keith
NPI 1821016619
$49,315.12
in general payments reported to CMS, 2019-2025
6 companies · $15.47 in 2025
The $15.47 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $6,930 · 2021: $9,739 · 2022: $11K · 2023: $550 · 2024: $617 · 2025: $15.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,100 · Food and Beverage: $82.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,100.00 |
| Food and Beverage | $82.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $23,222.03 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $8,200.00 | 2022 | |
| Astrazeneca Uk Limited | $7,852.00 | 2020-2022 | |
| Daiichi Sankyo INC. | $7,308.20 | 2019 | |
| Merck Sharp & Dohme LLC | $2,650.00 | 2019-2024 | |
| Medtronic, INC. | $82.89 | 2024-2025 | Illumisite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Keith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.